Yvonne Greenstreet, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 50,937 shares at $306.00 ($15.5M) on 2025-06-02, disclosed to the SEC on 2025-06-03.
Scheduled sale ($15.5M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $304.00 | 25,469 | $7.7M | 49.8% |
| 2 | $306.00 | 6,171 | $1.9M | 12.2% |
| 3 | $306.00 | 19,297 | $5.9M | 38.0% |
| Total | $305.00 avg | 50,937 | $15.5M | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $2.2M | — | Filing → |
| ALNY | SELL | 2026-01-14 | $3.5M | — | Filing → |
| ALNY | SELL | 2025-11-14 | $23.2M | — | Filing → |